Do you want to read an article? Please log in or register.
Patient-Reported Importance of Functional Benefit in Geographic Atrophy
Further Publications
Related content
Macular Diseases
Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From The Phase 3 Oaks Trial: Microperimetry: Visual Function Benefit With Pegcetacoplan
Am J Ophthalmol
Chakravarthy U, Schwartz R, Guymer RH, Holz FG, Rachitskaya AV, Vujosevic S, Lewis P, Vorwerk H, Alibhai AY, Moult EM, Morales MU, Bliss C, Baumal CR, Waheed NK
doi: 10.1016/j.ajo.2025.02.012
Further Publications
Evaluating the Progression of Retinal Sensitivity Loss in Geographic Atrophy Using Machine-Learning-Based Structure-Function Correlation (OMEGA 2)
Invest Ophthalmol Vis Sci
Ansari G, Schärer N, Pfau K, Valmaggia P, Gabrani C, Zuche H, Giani A, Esmaeelpour M, Yamaguchi TC, Feltgen N, Maloca PM, Schmetterer L, Scholl HPN, Pfau M
doi: 10.1167/iovs.66.11.34
COMMENTED
Macular Diseases
Alcohol Consumption and Risk of Age-Related Macular Degeneration and Geographic Atrophy Progression: AREDS2 Report 34
★ 3
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Ophthalmol Retina
Duic C, Vance E, Agrón E, Keenan TDL, AREDS2 Research Group
doi: 10.1016/j.oret.2024.11.006
Retinal Diseases
Three-Year Clinical Outcomes in Geographic Atrophy: An Analysis of 18,712 Patient Eyes
Retina
Shughoury A, Boucher N, Aggarwal N, Ciulla TA
doi: 10.1097/IAE.0000000000004285
Macular Diseases
Long-Term Natural History of Treatment-Naïve Geographic Atrophy in Age-Related Macular Degeneration
Transl Vis Sci Technol
Muth DR, Quérat L, Venkataraman AP, Dominguez-Vicent A, Petrovski G, Williams PA, Locri F, Zweifel SA, Kvanta A
doi: 10.1167/tvst.14.5.5
Macular DiseasesRetinal Diseases
Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study: Ocular Adverse Events of Pegcetacoplan & Avacincaptad Pegol
Am J Ophthalmol
Kailani Z, Mihalache A, Popovic MM, Kertes PJ, Muni RH
doi: 10.1016/j.ajo.2025.04.022
Ocular Oncology
Choroidal melanoma patient views on the importance of treatment characteristics and outcomes, and physicians' information provision in the Netherlands
Acta Ophthalmol
Shirzada A, Pieterse AH, Vlug L, Luyten GPM, Vu THK, Bleeker JC, Bakker PA, Marinkovic M, Rasch CRN, Horeweg N, van den Akker-Van Marle ME
doi: 10.1111/aos.17505
Surgery and InterventionCataracts
Factors influencing outcome satisfaction after cataract surgery: patient-reported insights from the RayPro database
BMC Ophthalmol
Botta J, Barsam A, Dmitriew A, Zaldivar R, Wiley WF, Windsor S
doi: 10.1186/s12886-024-03800-3
Macular Diseases
Real-World Experience with Intravitreal Pegcetacoplan for the Treatment of Geographic Atrophy in Age-Related Macular Degeneration
Am J Ophthalmol
Shen M, Berni A, Liu J, Hiya F, Herrera G, El-Mulki OS, Beqiri S, Cheng Y, Kastner J, Trivizki O, Kumar S, Zhang Y, Le VH, O'Brien RC, Nicola MD, Yehoshua Z, Dubovy SR, Wang RK, Gregori G, Rosenfeld PJ
doi: 10.1016/j.ajo.2025.09.006